Zenas BioPharma, Inc. (ZBIO) Return on equity 2024–2025
Zenas BioPharma, Inc. (ZBIO) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-156.0%FY2025 · since FY2024: -50.2% → -156.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -156.0% | -105.8 pp |
| FY2024 | -50.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice